Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Ventrax™ Delivery System (VTR851)

K-Number: K231246 · 2023-08-30

ApplicantMerit Medical Systems, Inc.
Decision Date2023-08-30
Product CodeDQY
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

Ventrax™ Delivery System (VTR851) is a medical device manufactured by Merit Medical Systems, Inc.. It received FDA 510(k) clearance on 2023-08-30 under approval number K231246. The device is classified under product code DQY. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Ventrax™ Delivery System (VTR851)?

Ventrax™ Delivery System (VTR851) is a medical device that received FDA 510(k) clearance on 2023-08-30. It is manufactured by Merit Medical Systems, Inc.. The 510(k) number is K231246.

When was Ventrax™ Delivery System (VTR851) approved by the FDA?

Ventrax™ Delivery System (VTR851) received FDA 510(k) clearance on 2023-08-30, under approval number K231246.

What company makes Ventrax™ Delivery System (VTR851)?

Ventrax™ Delivery System (VTR851) is manufactured by Merit Medical Systems, Inc..

What is the FDA product code for Ventrax™ Delivery System (VTR851)?

The FDA product code for Ventrax™ Delivery System (VTR851) is DQY.

Related Clinical Trials

NCT07039942 French Prospective Multicentric Study in Real World RECRUITING NCT06728059 Safety and Feasibility of a Machine-Learning Bolus Priming Added to Existing Control Algorithm COMPLETED NCT07458243 A Prospective, Multicenter, Single Arm Registry of ENROUTE NPS in Conjunction With Carotid WALLSTENT in Chinese Population NOT_YET_RECRUITING NCT07430293 Hybrid Closed-Loop Insulin Delivery After Pancreatectomy RECRUITING NCT04414280 The Impact of Hybrid Closed-loop Insulin Delivery in Type 1 Diabetes on Glycemic Control and PROMs ACTIVE_NOT_RECRUITING NCT06847542 A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD RECRUITING

Other Devices by Merit Medical Systems, Inc.

K161921SwiftNINJA Microcatheter K162777Squirt Fluid Delivery System K161392Elation Pulmonary Balloon Dilation K160107DiamondTOUCH Inflation Device and Fluid Dispensing Syringe K151967Centros Long-Term Hemodialysis Catheter, CentrosFLO Long-Term Hemodialysis Catheter K153337Corvocet Biopsy System

View all 65 devices →

Related Devices (Code: DQY)

K163000AMPLATZER TorqVue 45x45 Delivery SheathAga Medical COrporation (Wholly Owned by St. Jude Medical CO K160561Boosting CatheterQxmedical, LLC K161546R2P SlenGuideAshitaka Factory of Terumo Corporation K161152Navien Intracranial Support CatheterMicro Therapeutics, Inc. d/b/a ev3 Neurovascular K162384TrailBlazer Angled Support CatheterMedtronic Vascular, Inc.(Formerly Ev3 Inc.) K162359Surefire Guiding CatheterSurefire Medical, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑